Not finding it? Sign in to also search OpenAlex live.
-
LB1531B. Administration of the TNF-alpha inhibitor, infliximab, reduces mortality in hospitalized patients with COVID pneumonia. Results of a randomized controlled trial
Jane A. O’Halloran, Kevin Joseph Anstrom, Eyal Kedar, Matthew William McCarthy, Emily R. Ko, Richard Melsheimer, +4 more
0citations -
#3345 Nefecon provides kidney benefit irrespective of baseline eGFR in patients with IgAN: a subanalysis of the NefIgArd study2025 Nephrology Dialysis Transplantation article Medicine Renal Diseases and Glomerulopathies Open access
Jonathan Barratt, Richard A. Lafayette, Heather N. Reich, Jens Halkjaer Kristensen, Russell F Jones, Jürgen Floege, +4 more
0citations -
Non-steroidal anti-inflammatory drugs for acute gout2021 Cochrane Database of Systematic Reviews article Medicine Gout, Hyperuricemia, Uric Acid Open access
Caroline MPG van Durme, Mihir D. Wechalekar, Robert Landewé, Jordi Pardo Pardo, Sheila Cyril, Désirée M F M van der Heijde, +1 more
44citations -
Summary measures in non-inferiority clinical trials with a time-to-event outcome: an empirical comparison of power2025 BMC Medical Research Methodology article Mathematics Statistical Methods in Clinical Trials Open access
Shole D.L. Broer, Ian R. White, Tim Peter Morris, Isabelle R. Weir, Marta F. Fiocco, Matteo Quartagno
0citations -
Effects of linagliptin vs glimepiride stratified by prior insulin secretagogue use in the cardiovascular outcome study of linagliptin versus glimepiride in type 2 diabetes (CAROLINA) trial
Darren K. McGuire, J Rosenstock, Odd-Erik Johansen, Bernard Zinman, Kamlesh K. Khunti, Michaela Mattheus, +3 more
1citations -
Critical appraisal of combination therapies: the impact of trial design on benefit-risk outcomes2026 JNCI Journal of the National Cancer Institute article Mathematics Statistical Methods in Clinical Trials
Floor de Jong, Li-Anne H Douma, Paul Baas, Cornedine Jannette de Gooijer, Hans A. J. Gelderblom, Jacobus A. Burgers, +1 more
0citations -
Alirocumab and Cardiovascular Outcomes in Patients With Previous Myocardial Infarction: Prespecified Subanalysis From ODYSSEY OUTCOMES2022 Canadian Journal of Cardiology article Medicine Lipoproteins and Cardiovascular Health Open access
Chern‐En Chiang, Gregory G. Schwartz, Yedid Elbez, Michael J. Szarek, Deepak L. Bhatt, Vera Bittner, +11 more
14citations -
A prospective, randomized, controlled, double-blind, multi-center study to evaluate the efficacy and safety of a blue light device for the treatment of chronic back pain2024 Frontiers in Pain Research article Medicine Laser Applications in Dentistry and Medicine Open access
Ralf Baron, Bart J. Morlion, Albert Dahan, Michael A. Überall, Golo von Basum, Imane Wild
4citations -
Efficacy of Fremanezumab in Male Patients With Migraine and Documented Inadequate Response to 2–4 Classes of Migraine Preventive Medication Classes: Results of the Randomized, Placebo-controlled FOCUS Study (4339)
Antoinette MaassenVanDenBrink, Gisela Marie Terwindt, Joshua M. Cohen, Ronghua Yang, Verena Ramirez-Campos, Maja Galić, +2 more
0citations -
PEMBROLIZUMAB VS PLACEBO PLUS PACLITAXEL WITH OR WITHOUT BEVACIZUMAB FOR PLATINUM-RESISTANT RECURRENT OVARIAN CANCER: RESULTS BY HISTOLOGIC SUBTYPE FROM THE PHASE 3 ENGOT-OV65/KEYNOTE-B96 STUDY2026 International Journal of Gynecological Cancer article Medicine Ovarian cancer diagnosis and treatment
Nicoletta Colombo, Emese Zsíros, Al Covens, Radosław Mądry, Pamela Salman, Mihai Meirovitz, +14 more
1citations -
Faible activité et rémission sous filgotinib [FIL] chez les patients PR ayant présenté une réponse inadéquate aux bDMARDs: analyse en sous-groupes de l’étude de phase 3 FINCH2
Jacques‐Eric Gottenberg, Maya H Buch, Roberto Felice Caporali, KENNETH C. KALUNIAN, Alena Pechonkina, Shijia Rao, +3 more
0citations -
POS1046 IMPROVEMENTS IN PATIENT-REPORTED IMPACT OF PSORIATIC ARTHRITIS WITH IL-12/23 (USTEKINUMAB) OR TUMOUR NECROSIS FACTOR INHIBITORS: 1-YEAR DATA FROM THE LARGE, REAL-WORLD PsABIO STUDY2021 Annals of the Rheumatic Diseases article Medicine Spondyloarthritis Studies and Treatments Open access
Laure Gossec, Stefan Siebert, Paul Bergmans, Kurt de Vlam, Elisa Gremese, Beatriz E. Joven-Ibáñez, +6 more
0citations -
Efficacité et tolérance d’upadacitinib chez des patients atteints de spondylarthrite ankylosante et ayant eu une intolérance et/ou un manque d’efficacité lors d’un traitement antérieur par biologique : analyse en sous-groupes
Xenofon Baraliakos, Fabiana Ganz, Hideto Kameda, Jessica A. Walsh, Manish Jain, K. D'silva, +5 more
0citations -
Effet du sécukinumab versus adalimumab biosimilaire sur la progression radiographique chez les patients atteints de spondyloarthrite axiale radiographique : analyse en sous-groupes avec sur le statut syndesmophytes et protéine C-réactive à l’inclusion
Christian Hubert Roux, Denis Poddubnyy, Désirée M F M van der Heijde, D. Atul, Pedro Machado, Victoria Navarro‐Compán, +13 more
0citations -
Results in Subgroups with Unmet Need in the Summit Trial: Bezuclastinib in Adults with Non-Advanced Systemic Mastocytosis2026 Journal of Allergy and Clinical Immunology article Immunology and Microbiology Mast cells and histamine Open access
John M. Fahrenholz, Nathan Boggs, Lindsay A. M. Rein, Prithviraj Bose, Vito Sabato, Cecilia Arana Yi, +18 more
0citations